There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mirum Pharmaceuticals (MIRM – Research Report) and Baxter International (BAX – Research Report) with bullish sentiments. Mirum Pharmaceuticals (MIRM) In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Mirum Pharmaceuticals, with a price target of $32.00. The company's shares closed last Friday at $25.58. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-and-baxter-international-bax?utm_source=advfn.com&utm_medium=referral
Mirum Pharmaceuticals (NASDAQ:MIRM)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Mirum Pharmaceuticals Charts.
Mirum Pharmaceuticals (NASDAQ:MIRM)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Mirum Pharmaceuticals Charts.